Multiple myeloma: treatment options for an incurable disease.
Multiple myeloma remains a challenge for the treating physician, with extremely low complete response rates (5-10%) to conventional induction therapy. High dose therapy with autologous hematopoietic stem cell transplant results in improved response, event-free and overall survival and should be considered the standard of care for patients who are candidates for transplantation. Several newer treatment option are now available.
Pandit
S R
SR
Division of Neoplastic Diseases and Related Disorders (Hematology-Oncology), Medical College of Wisconsin, Milwaukee 53226, USA.
D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis